lobbying_activities: 1301823
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1301823 | 753afa1c-b323-46f5-86a5-2a520b466de9 | Q3 | WINSTON & STRAWN LLP | 41682 | FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) | 2012 | third_quarter | PHA | Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-10-17T09:36:15.990000-04:00 |